You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anti-SIRPα therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma Trial (HCB101)

Not yet recruiting
  • Advanced Solid Tumor
  • Refractory Non-Hodgkin Lymphoma
  • (no location specified)
May 28, 2023

Hematologic Malignancy Trial in Tianjin (IMM01)

Terminated
  • Hematologic Malignancy
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Sciences and Peking Union Medical Col
May 5, 2023

Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,

Not yet recruiting
  • Muscle-Invasive Bladder Carcinoma
  • +2 more
  • Guangzhou, Guangdong, China
    Cancer Center, Sun Yat-sen University
Aug 3, 2023

Therapy of Anti-NMDAR Encephalitis at Diagnosis

Active, not recruiting
  • Anti-NMDA (N-Methyl D-Aspartate) Receptor Encephalitis
    • Rotterdam, Netherlands
      Erasmus Medical Center
    Sep 4, 2023

    Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

    Recruiting
    • Acute Myeloid Leukemia Refractory
    • Acute Myeloid Leukemia, in Relapse
    • anti Tim-3/CD123 CAR-T cell therapy
    • Xuzhou, Jiangsu, China
      Kailin Xu
    Nov 4, 2023

    Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1 Trial in Shanghai (Camrelizumab (anti-PD-1 inhibitor), Apatinib

    Recruiting
    • Oral Squamous Cell Carcinoma
    • +3 more
    • Camrelizumab (anti-PD-1 inhibitor)
    • Apatinib (anti-VEGFR inhibitor)
    • Shanghai, Shanghai, China
      Ninth People's Hospital, Shanghai Jiao Tong University School of
    Oct 8, 2022

    Gut Microbiome in Anti-tumor Therapy Induced Diarrhea

    Recruiting
    • Cancer
      • Graz, Austria
        Department of Internal Medicine, Medical University of Graz
      May 15, 2023

      Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

      Not yet recruiting
      • Multiple Sclerosis
      • +2 more
      • KYV-101 anti-CD19 CAR-T cell therapy
      • Standard lymphodepletion regimen
      • Palo Alto, California
        Stanford Multiple Sclerosis Center
      Nov 13, 2023

      Lupus Nephritis, Lupus Nephritis - World Health Organization (WHO) Class III, Lupus Nephritis - WHO Class IV Trial in Denver,

      Recruiting
      • Lupus Nephritis
      • +2 more
      • KYV-101 anti-CD19 CAR-T cell therapy
      • Standard lymphodepletion regimen
      • Denver, Colorado
      • +1 more
      Jul 7, 2023

      A Cohort Study on Anti-microbial Stewardship in PICU

      Not yet recruiting
      • Infections
      • antimicrobial therapy
      • (no location specified)
      May 8, 2023

      Coronary Artery Disease Trial in Seoul (Clopidogrel monotherapy, Tailored anti-platelet therapy)

      Not yet recruiting
      • Coronary Artery Disease
      • Clopidogrel monotherapy
      • Tailored anti-platelet therapy
      • Seoul, Korea, Republic of
        Severance Hospital
      Jul 3, 2023

      Lymphoma Trial in Houston (PCV20)

      Not yet recruiting
      • Lymphoma
      • PCV20
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 20, 2023

      Breast Tumor Female Trial in Beijing (CDK4/6 inhibitor (Qilu),Trastuzumab (Hanquyou))

      Recruiting
      • Breast Neoplasm Female
      • CDK4/6 inhibitor (Qilu),Trastuzumab (Hanquyou)
      • Beijing, Beijing, China
      • +1 more
      Jul 31, 2023

      Following Intensive Anti-VEGF Therapy in Wet AMD

      Completed
      • Age-Related Macular Degeneration
      • Budapest, Hungary
      • +1 more
      Dec 28, 2022

      Gastroesophageal Reflux Trial in Munich (Anti reflux mucosal ablation (ARMA), Sham procedure)

      Recruiting
      • Gastroesophageal Reflux
      • Anti reflux mucosal ablation (ARMA)
      • Sham procedure
      • Munich, Bayern, Germany
        II Medizinische Klinik am Klinikum rechts der Isar der Technisch
      Mar 8, 2023

      18F-HER2 PET Trial in Hangzhou (18F-HER2 PET)

      Not yet recruiting
      • 18F-HER2 PET
      • 18F-HER2 PET
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital, Zhejiang University School of med
      Aug 2, 2023

      Relapsing Multiple Sclerosis Trial in Fort Collins, Farmington (Ublituximab)

      Recruiting
      • Relapsing Multiple Sclerosis
      • Ublituximab
      • Fort Collins, Colorado
      • +1 more
      May 26, 2023

      Clinical Relevance of Small Airways Disease in Severe Asthma

      Recruiting
      • Asthma
        • Leeuwarden, Netherlands
          Medical Center Leeuwarden
        Jan 23, 2023

        Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections Trial in Pittsburgh (Specific T- Lymphocytes)

        Not yet recruiting
        • Adenovirus
        • +2 more
        • Specific T- Lymphocytes
        • Pittsburgh, Pennsylvania
          UPMC Children's Hospital of Pittsburgh
        Sep 8, 2023

        Gastroesophageal Reflux Disease Trial (Antireflux mucosal ablation, Sham procedure)

        Not yet recruiting
        • Gastroesophageal Reflux Disease
        • Antireflux mucosal ablation
        • Sham procedure
        • (no location specified)
        Oct 26, 2023

        Pneumococcal Vaccination in Patients With Anti-TNF Alpha Therapy

        Not yet recruiting
        • Pneumococcal Vaccine
        • Pneumococcal vaccine
        • Pontoise, France
          Internal Medicine Department - NOVO Hospital - Pontoise site
        Mar 28, 2023

        Oral Mucositis, Pediatric Cancer Trial in Riyadh (Curcumin, Laser)

        Not yet recruiting
        • Oral Mucositis
        • Pediatric Cancer
        • Riyadh, Ar Riyadh, Saudi Arabia
          Riyadh Elm University
        Sep 15, 2023

        Dental Care and Initiation of Anti-osteoporotic Therapy

        Completed
        • Dental Condition
        • Osteoporosis
        • NICE Cedex 1, Chun, France
          CHU de NICE
        Jan 30, 2023

        Primary Sjogren's Syndrome Trial (LY3361237)

        Not yet recruiting
        • Primary Sjogren's Syndrome
        • (no location specified)
        Mar 20, 2023

        Thyroid Dysfunction Induced by Anti-PD-1 Therapy in Advanced

        Completed
        • Carcinoma
        • no intervention
        • Jinan, Shandong, China
          Qilu Hospital, Shandong University
        Oct 23, 2022